Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
54
JYNT Quote, Financials, Valuation and Earnings
Last price:
$8.91
Seasonality move
:
14.26%
Day range:
$8.66 - $8.99
52-week range:
$7.50 - $13.47
Dividend yield:
0%
P/E ratio:
76.76x
P/S ratio:
2.48x
P/B ratio:
5.80x
Volume:
108.6K
Avg. volume:
131.8K
1-year change:
-11.31%
Market cap:
$131.6M
Revenue:
$52.2M
EPS (TTM):
$0.12
Analysts' Opinion
-
Consensus RatingThe Joint Corp. (United States) has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $10.67, The Joint Corp. (United States) has an estimated upside of 20.53% from its current price of $8.94.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $9.00 representing -1.7% downside risk from its current price of $8.94.
Fair Value
-
According to the consensus of 4 analysts, The Joint Corp. (United States) has 20.53% upside to fair value with a price target of $10.67 per share.
JYNT vs. S&P 500
-
Over the past 5 trading days, The Joint Corp. (United States) has underperformed the S&P 500 by -2.83% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
The Joint Corp. (United States) does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
The Joint Corp. (United States) has grown year-over-year revenues for 4 quarters straight. In the most recent quarter The Joint Corp. (United States) reported revenues of $13.4M.
Earnings Growth
-
The Joint Corp. (United States) has grown year-over-year earnings for 2 quarters straight. In the most recent quarter The Joint Corp. (United States) reported earnings per share of $0.06.
Enterprise value:
103M
EV / Invested capital:
4.15x
Price / LTM sales:
2.48x
EV / EBIT:
777.12x
EV / Revenue:
1.89x
PEG ratio (5yr expected):
--
EV / Free cash flow:
63.08x
Price / Operating cash flow:
82.71x
Enterprise value / EBITDA:
59.16x
Gross Profit (TTM):
$41.2M
Return On Assets:
-0.39%
Net Income Margin (TTM):
-0.54%
Return On Equity:
-1.38%
Return On Invested Capital:
-1.2%
Operating Margin:
3.86%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $114.8M | $50.2M | $54.4M | $12.7M | $13.4M | |
| Gross Profit | $95.7M | $35.4M | $41.2M | $9.5M | $10.3M | |
| Operating Income | $1.5M | -$1.2M | $132.5K | -$461.2K | $516K | |
| EBITDA | $10.4M | $2.4M | $1.7M | -$115.4K | $962.7K | |
| Diluted EPS | $0.14 | -$1.14 | $0.12 | -$0.21 | $0.06 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $24.5M | $17.9M | $27.4M | $54.1M | $59.4M | |
| Total Assets | $81M | $88.3M | $98.6M | $79.6M | $69.4M | |
| Current Liabilities | $21.5M | $21.6M | $27.7M | $38.3M | $33M | |
| Total Liabilities | $51.9M | $56.8M | $63.3M | $59.1M | $46.7M | |
| Total Equity | $29.1M | $31.5M | $35.3M | $20.5M | $22.7M | |
| Total Debt | $17.1M | $19.5M | $19.3M | $6.2M | $1.9M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $16.5M | $8.7M | $3.1M | $3.4M | $1.8M | |
| Cash From Investing | -$10.5M | -$1.8M | $6.5M | -$93.9K | -$317.8K | |
| Cash From Financing | $196.6K | -$2M | -$873.1K | -$6.4K | -$1.7M | |
| Free Cash Flow | $18M | $7.7M | $1.6M | $3.2M | $1.5M | |
JYNT
Sector
Market Cap
$131.6M
$28.1M
Price % of 52-Week High
65.71%
51.39%
Dividend Yield
0%
0%
Shareholder Yield
2.25%
-1.49%
1-Year Price Total Return
-12.12%
-17.13%
Beta (5-Year)
1.301
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$8.89
200-day SMA
Sell
Level
$10.18
Bollinger Bands (100)
Sell
Level
8.23 - 10.35
Chaikin Money Flow
Buy
Level
1.4M
20-day SMA
Buy
Level
$8.69
Relative Strength Index (RSI14)
Buy
Level
58.25
ADX Line
Sell
Level
12.05
Williams %R
Neutral
Level
-27.8788
50-day SMA
Buy
Level
$8.41
MACD (12, 26)
Buy
Level
0.15
25-day Aroon Oscillator
Buy
Level
52
On Balance Volume
Neutral
Level
2.9M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.0084)
Sell
CA Score
(Annual)
Level (-1.3682)
Buy
Beneish M-Score
(Annual)
Level (-3.4452)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (5.7244)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
The Joint Corp. engages in the revolutionizing access to chiropractic care by making quality healthcare affordable for patients seeking pain relief and ongoing wellness. It operates through the Corporate Clinics and Franchise Operations segments. The Corporate Clinics segment consists of the operating activities of the company-owned or managed clinics. The Franchise Operations segment includes the operating activities of the franchise business unit. The Joint was founded by Fred Gerretzen, Charles Barnwell, John Leonesio, Todd Welker, Barbara Holland, Steven P. Colmar, Craig P. Colmar, and Richard Rees on March 10, 2010 and is headquartered in Scottsdale, AZ.
Stock Forecast FAQ
In the current month, JYNT has received 1 Buy ratings 3 Hold ratings, and 0 Sell ratings. The JYNT average analyst price target in the past 3 months is $10.67.
-
Where Will The Joint Corp. (United States) Stock Be In 1 Year?
According to analysts, the consensus estimate is that The Joint Corp. (United States) share price will rise to $10.67 per share over the next 12 months.
-
What Do Analysts Say About The Joint Corp. (United States)?
Analysts are divided on their view about The Joint Corp. (United States) share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that The Joint Corp. (United States) is a Sell and believe this share price will drop from its current level to $9.00.
-
What Is The Joint Corp. (United States)'s Price Target?
The price target for The Joint Corp. (United States) over the next 1-year time period is forecast to be $10.67 according to 4 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is JYNT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for The Joint Corp. (United States) is a Hold. 3 of 4 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of JYNT?
You can purchase shares of The Joint Corp. (United States) via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase The Joint Corp. (United States) shares.
-
What Is The The Joint Corp. (United States) Share Price Today?
The Joint Corp. (United States) was last trading at $8.91 per share. This represents the most recent stock quote for The Joint Corp. (United States). Yesterday, The Joint Corp. (United States) closed at $8.94 per share.
-
How To Buy The Joint Corp. (United States) Stock Online?
In order to purchase The Joint Corp. (United States) stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get JYNT Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
JYNT
Sector
P/E ratio
76.76x
23.89x
PEG ratio
--
-0.01x
P/B ratio
5.80x
1.81x
Price / LTM sales
2.48x
1.59x
Growth Metrics
JYNT
Sector
Revenue growth
5.74%
4.62%
Earnings growth
126.23%
11.06%
Revenue (5-year growth)
1.49%
6.5%
Earnings forecast
--
-$0.21
Profitability
JYNT
Sector
Profitability FY 2024
$39.3M
$3.6M
Return on invested capital
-1.2%
-31.84%
Return on assets
-0.39%
-27.96%
Return on equity
-1.38%
-37.63%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Mar
12
Estimated Next Earnings Date
Feb
5
Balance Sheet
JYNT
Sector
Total cash
$30.7M
$26.4M
Short term investments
--
$25.7M
Total assets
$83.2M
$76.9M
Long term debt
$1.9M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
85
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
63
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
